
The first and only FDA-approved topical growth factor for diabetic foot ulcers. Regranex stimulates wound healing by promoting cell proliferation and new tissue formation.
Regranex (becaplermin) is a recombinant human platelet-derived growth factor (PDGF-BB) gel approved by the FDA specifically for lower extremity diabetic neuropathic ulcers that extend into subcutaneous tissue or beyond.
PDGF is one of the body's natural wound healing signals. It stimulates fibroblast proliferation, angiogenesis (new blood vessel formation), and granulation tissue development—all critical for wound closure.
First topical growth factor approved for diabetic foot ulcers
Clinical studies show 30-50% improvement in healing rates
Reimbursed under Medicare Part B for qualifying ulcers

Stimulates fibroblast division and migration
Promotes new blood vessel formation
Accelerates formation of healthy wound bed
Promotes wound edges to contract and close
Debride and remove necrotic tissue, rinse with saline
Measured amount spread evenly over wound surface
Moist saline gauze covered with secondary dressing
Applied once daily for up to 20 weeks or until healed
Our specialists will evaluate if you're a candidate for growth factor therapy
Minima consequat excepturi sociis? Tempore lacus asperiores facilisis rem eu nam hic animi eaque tellus, tempus! Pellentesque excepteur feugiat rutrum faucibus primis, eget auctor nullam.
Minima consequat excepturi sociis? Tempore lacus asperiores facilisis rem eu nam hic animi eaque tellus, tempus! Pellentesque excepteur feugiat rutrum faucibus primis, eget auctor nullam.

Minima consequat excepturi sociis? Tempore lacus asperiores facilisis rem eu nam hic animi eaque tellus, tempus! Pellentesque excepteur feugiat rutrum faucibus primis, eget auctor nullam.

Minima consequat excepturi sociis? Tempore lacus asperiores facilisis rem eu nam hic animi eaque tellus, tempus! Pellentesque excepteur feugiat rutrum faucibus primis, eget auctor nullam.
Healix360 Advanced mobile wound care specialists connecting patients with regenerative healing solutions. Medicare Part B accepted.
6618 San Fernando Rd Glendale Ca 91201
Copyright © 2026 Healix360.com. All Rights Reserved.
At Healix360, we specialize in providing advanced wound care solutions tailored specifically for diabetic foot ulcers. Our focus on innovative treatments, such as Regranex, allows us to address the unique challenges faced by patients with diabetic neuropathies. We aim to educate both patients and healthcare providers about the importance of effective wound management to prevent complications and improve quality of life.
Diabetic foot ulcers are a common and serious complication of diabetes, often leading to severe health issues if not treated properly. By utilizing FDA-approved treatments like Regranex, we can significantly enhance healing rates and reduce the risk of infections and amputations. Our commitment to comprehensive care ensures that patients receive the best possible outcomes.
Diabetic foot ulcers are open sores or wounds that occur on the feet of individuals with diabetes, primarily due to nerve damage and poor circulation. These ulcers can develop from minor injuries, pressure, or skin breakdown, making it crucial for patients to understand the risks and symptoms associated with them. Early identification and intervention are key to successful treatment.
Statistics show that nearly 15% of people with diabetes will develop a foot ulcer in their lifetime. If left untreated, these ulcers can lead to serious complications, including infections and even amputations. Awareness and education about diabetic foot ulcers can empower patients to seek timely medical attention and adopt preventive measures.
Healthcare providers play a critical role in the management and treatment of diabetic foot ulcers. They are responsible for assessing the severity of the ulcer, recommending appropriate treatments, and monitoring the healing process. Collaboration between patients and providers is essential to ensure effective wound care and to tailor treatment plans to individual needs.
Providers must be knowledgeable about the latest advancements in wound care, including the use of Regranex and other innovative therapies. Regular follow-ups and patient education about proper foot care can significantly enhance healing outcomes and reduce the risk of recurrence, leading to improved patient satisfaction and overall health.
Hearing from patients who have successfully healed their diabetic foot ulcers can provide hope and encouragement to others facing similar challenges. Testimonials highlight the effectiveness of Regranex and the importance of following a comprehensive treatment protocol. These stories not only showcase the positive outcomes but also emphasize the critical role of timely intervention.
Many patients report significant improvements in their quality of life after receiving treatment at Healix360. Their experiences underline the importance of seeking specialized care and adhering to prescribed treatment plans, which can lead to successful healing and a return to normal activities.
Frequently asked questions (FAQs) about Regranex and wound care can help demystify the treatment process for patients. Common inquiries include how Regranex works, potential side effects, and the expected timeline for healing. Addressing these questions can alleviate concerns and empower patients to make informed decisions about their care.
Providing clear and concise answers to FAQs not only enhances patient understanding but also builds trust between patients and healthcare providers. By ensuring that patients feel informed and supported, we can foster a collaborative environment that promotes effective wound management and healing.